leadf
logo-loader
viewValiRx PLC

ValiRx Plc enjoying strong industry interest in its cancer treatments

George Morris, chief operations officer at ValiRx Plc (LON:VAL), updates Proactive's Andrew Scott on developments across the company's portfolio.

Morris says advanced conversations are continuing with possible partners as they look to press ahead with the development of their flagship VAL401 lung cancer candidate.

Quick facts: ValiRx PLC

Price: 20.5 GBX

AIM:VAL
Market: AIM
Market Cap: £13.4 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

K2fly welcomes new five-year SaaS deal with Coeur Mining

K2fly Ltd's (ASX:K2F) Nic Pollock caught up with Proactive's Andrew Scott following the news they've signed a five-year resource inventory management software as a service contract with New York Stock Exchange-listed precious metals mining company Coeur Mining Inc (NYSE:CDE) (FRA:CDM1). This...

7 hours, 6 minutes ago

2 min read